This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring
THE SPRINGTIME PARTNERING EVENT
March 17–19, 2025 | Milan, ItalyMarch 25–26, 2025 | Digital Partnering

Present your company at BIO-Europe Spring

Showcase your innovations to an audience of top-tier investors, biopharma execs and potential partners at BIO-Europe Spring and tap into the funding to drive your business forward.

Priority Review Deadline to Apply: January 20, 2025

Priority review deadlines

The deadline to apply for the second review round is January 20, 2025.

Round 1 | Deadline: November 22, 2024

Round 2 | Deadline: January 20, 2025

PRESENTATION OPTIONS

Whether you represent a pharma company or an academic innovator, BIO-Europe Spring offers a company presentation option for all companies—both in-person and digitally.

All-Access Presentation

A small group of companies will be selected to present onsite at the event. Please submit your application today to be considered for an in-person presentation.

Benefits of an all-access presentation:

  • Increased visibility. Showcase your breakthroughs with a presentation timeslot onsite at BIO-Europe Spring.
  • Generate interest. Raise your company’s profile and get in front of BD executives, top-tier VCs, pharma and private equity investors.

An In-person Company Presentation Includes:

  • A presentation slot during BIO-Europe Spring, March 17-19, 2025
  • Your pre-recorded presentation added to your partnering profile six weeks before the event for on-demand viewing by registered attendees.

Fee structure

  • Biotech and Midsize Pharma
    • EUR 1,250
  • Academic Innovator and Next Generation
    • EUR 715



Digital Presentation

Gain weeks of exposure and book more one-to-one meetings with a digital presentation.

Benefits of a digital presentation:

  • Increased exposure. Your virtual presentation can be viewed on-demand by attendees up to six weeks prior to the event, and throughout the conference.
  • More one-to-one meetings. Your virtual presentation in partnering ONE® will include a link for attendees to schedule one-to-one meetings with your company. Based on data from previous EBD events, presenting companies receive up to 25% more meeting requests.
  • Targeted exposure. Digital presentations will be featured for a certain amount of time in partneringONE® and on an event digest email to registered attendees.

A Digital Company Presentation Includes:

  • Your pre-recorded presentation added to your partnering profile six weeks before the event for on-demand viewing by registered attendees.
  • Your one minute pre-recorded elevator pitch streamed onsite during BIO-Europe Spring, March 17 - 19, 2025

Fee Structure

  • Biotech and Midsize Pharma
    • EUR 900
  • Academic Innovator and Next Generation
    • EUR 365

PRESENTATION TRACKS

Biotech Company Presentations

In this track, biotech companies can seek partnership for their products, initiate strategic alliances and tap into the global financing network.

View Biotech Presentation Categories Here

Next Generation Presentations

This track is the most direct way for early stage projects and small entrepreneurial companies to get their innovative asset or idea directly in front of potential partners.

Companies to be considered for Next Generation Presentation need to meet the following criteria:

  • Created in the past three years
  • Fewer than 20 employees
  • Developing new therapeutic products or offering an innovative service

Academic Innovators Presentations

Academic researchers and technology transfer offices can apply to present their asset or idea to funding and development partners.

For more information, contact:

Olivia Guiliana
EBD Group
oguiliana@ebdgroup.com

Click here for information on cancellation policy, payments, and sending a replacement.